Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants

Coronavirus disease 2019, caused by SARS-CoV-2, remains an on-going pandemic, partly due to the emergence of variant viruses that can “break-through” the protection of the current vaccines and neutralizing antibodies (nAbs), highlighting the needs for broadly nAbs and next-generation vaccines. We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Bo-Seong, Cha, Jeong Seok, Hwang, Insu, Kim, Uijin, Adolf-Bryfogle, Jared, Coventry, Brian, Cho, Hyun-Soo, Kim, Kyun-Do, Oh, Byung-Ha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765073/
https://www.ncbi.nlm.nih.gov/pubmed/35030983
http://dx.doi.org/10.1080/19420862.2021.2021601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765073/
https://www.ncbi.nlm.nih.gov/pubmed/35030983
http://dx.doi.org/10.1080/19420862.2021.2021601

Ejemplares similares